Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E2197: Doxorubicin/Docetaxel vs Doxorubicin/Cyclophosphamide in Adjuvant Breast Cancer
NCT00003519Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Aug 1998
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in breast cancer, sponsored by Eastern Cooperative Oncology Group. Started Aug 1998; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003519.